University of Ioannina
Η έκφραση του OCT-4 και DAZL στις καλοήθειες παθήσεις του μαστού και σε καρκίνο του μαστού
Abstract
dc:descriptionPurpose:This study aims to detect the presence and expression of the Oct-4 and Dazl genes in benign diseases and cancerous breast tumors using two different laboratory methods. It also aims to determine the diagnostic value of anti-Müllerian hormone AMH in relation to 5-year recurrence-free and metastases-free survival after surgical removal.Material – Method:The study population consisted of 18 patients who had undergone radical modified or simple mastectomy surgery after a diagnosis of benign disease or breast cancer. For the detection and quantification of the Oct-4 and Dazl genes, both the Real-time qPCR technique with the LightCycler 480 machine and the immunohistochemistry technique using the Benchmark ULTRA VENTANA machine, where an automatic staining technique is performed, were performed. Finally, the hormonal determination of the AMH of the samples was done using the AMH Gen II Elisa.Results:The expression of both genes was negative by immunohistochemistry. Contrasted with the real-time polymerase chain reaction method all samples showed positive expression of the Oct-4 gene and 4 of 13 for the Dazl gene. 83% of the women in the study survived five years after surgical removal without developing any disease recurrence or cancer metastases, and during that time they had low levels of anti-Müllerian hormone in their blood serum.Conclusions:The present work showed that the results of the two laboratory methods aimed at determining the expression of the Oct-4 and Dazl genes in samples of benign diseases and breast cancer do not agree with each other. However, real-time qPCR detected a barely detectable expression of the Dazl gene and demonstrated a higher expression of the Oct-4 gene in grade 2 invasive lobular carcinoma samples compared to fibroadenomas and non-invasive lobular carcinomas and higher than 67 % of specimens involving invasive serous carcinomas. We therefore conclude that the Oct-4 gene is more expressed in cancer cells and mainly in glandular lobes than in breast ducts, suggesting that cancer cells, as they divide uncontrollably, may use the undifferentiated phenotype characteristic of stem cells, as a result of functional cooperation of Oct-4, Sox2 and Nanog.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Plakas, Georgios
- Πλάκας, Γεώργιος
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53957